Financhill
Back

Entrada Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
37

TRDA
Entrada Therapeutics

Last Price:
$17.60
Seasonality Move:
-24.47%
Buy
55

CPRX
Catalyst Pharmaceuticals

Last Price:
$21.26
Seasonality Move:
6.88%
Sell
37
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.27. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $17.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 41.98 Sell
Chaikin Money Flow: 106552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.67 - 20.29) Sell
Bollinger Bands (100): (15.2 - 18.88) Buy

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 45.6 Sell
Chaikin Money Flow: 513844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.15 - 22.07) Sell
Bollinger Bands (100): (19.14 - 22.14) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.02 Sell
20-day SMA: 19.27 Sell
50-day SMA: 18.48 Sell
200-day SMA: 15.77 Buy
8-day EMA: 18.11 Sell
20-day EMA: 18.7 Sell
50-day EMA: 18.33 Sell
200-day EMA: 16.47 Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.56 Sell
20-day SMA: 21.76 Sell
50-day SMA: 21.71 Sell
200-day SMA: 18.26 Buy
8-day EMA: 21.55 Sell
20-day EMA: 21.68 Sell
50-day EMA: 21.43 Sell
200-day EMA: 18.86 Buy

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):